Data protection Impressum

Medtech

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (August 2026)

31 August 2026

An interdisciplinary team from the University of Bern and Inselspital has developed CARESCORE, an AI model that calculates a patient's individual risk of postoperative infection within seconds of surgery ending, by drawing on vital signs recorded during the procedure.

Bern researchers develop an AI model that predicts infection risk at the end of surgery

31 August 2026

Distalmotion, the Lausanne-based medtech company, has received FDA 510(k) clearance for ventral hernia repair with its DEXTER Robotic Surgery System, completing its portfolio for the four highest-volume outpatient soft tissue procedures in the United States.

Distalmotion’s DEXTER robot cleared by the FDA for ventral hernia repair

20 August 2026

Spineart, the Geneva-based medtech company specializing in spine surgery, has received FDA approval for its BAGUERA C cervical disc for one and two contiguous levels, expanding access in the United States to a motion-preserving solution for cervical disc disease.

Spineart receives FDA approval for its BAGUERA C cervical disc

20 August 2026

A new study conducted at Bern’s University Hospital shows that VisionOne, the virtual reality eye-testing platform developed by Vaud-based PeriVision, delivers clinical performance comparable to the stationary perimeter considered the gold standard, including in advanced glaucoma.

PeriVision’s VR eye test matches the gold standard across glaucoma severity

17 August 2026

Actival, a CSEM spin-off based in Neuchâtel, has been awarded a CHF 1.4 million grant from Innosuisse to accelerate the development and market launch of its patented Active Splints, a new generation of dental aligners that dispense antibacterial fluid and fluoride.

Actival secures a CHF 1.4 million Innosuisse grant for its smart dental aligners

3 August 2026

HeroSupport, a Geneva-based medtech company, has announced that NYU Grossman School of Medicine is the first clinical site in the United States to participate in its SHIELD study evaluating the VENUS SHELL breast immobilization device.

HeroSupport opens its first US clinical site for the SHIELD study

3 August 2026

The .NeuroRestore center in Lausanne, led by Jocelyne Bloch and Grégoire Courtine, has been honored with the 2026 Grand Prix scientifique of the NRJ Foundation - Institut de France for its brain-spine interface that restores movement to paralyzed patients.

.NeuroRestore wins part of France’s 2026 NRJ Foundation science grand prix

13 July 2026

Geneva has been named European Capital of Brain Health 2026 by the European Academy of Neurology, in recognition of its research and innovation ecosystem.

Geneva named European Capital of Brain Health 2026

6 July 2026

Geneva-based medtech company ABCDx has reached several milestones with LVOCheck, its point-of-care platform for diagnosing large vessel occlusion stroke, including a peer-reviewed publication, the completion of a Eurostars project and the start of its industrialization.

Geneva’s ABCDx reaches several milestones with its acute stroke diagnostics platform

29 June 2026

1 2 3 4 5 … 16